%0 Journal Article
%T Best practices for machine learning in antibody discovery and development.
%A Wossnig L
%A Furtmann N
%A Buchanan A
%A Kumar S
%A Greiff V
%J Drug Discov Today
%V 29
%N 7
%D 2024 May 17
%M 38762089
%F 8.369
%R 10.1016/j.drudis.2024.104025
%X In the past 40 years, therapeutic antibody discovery and development have advanced considerably, with machine learning (ML) offering a promising way to speed up the process by reducing costs and the number of experiments required. Recent progress in ML-guided antibody design and development (D&D) has been hindered by the diversity of data sets and evaluation methods, which makes it difficult to conduct comparisons and assess utility. Establishing standards and guidelines will be crucial for the wider adoption of ML and the advancement of the field. This perspective critically reviews current practices, highlights common pitfalls and proposes method development and evaluation guidelines for various ML-based techniques in therapeutic antibody D&D. Addressing challenges across the ML process, best practices are recommended for each stage to enhance reproducibility and progress.